**7. References**


As shown across the sections of this chapter, the numerous hypothesis about pathogenic pathways of CCC have supporting data and pitfalls. Finally all proposals interact with each other, giving us the idea that none of these theories explains the very complex development of CCC by itself. Rather, it seems more feasible that all these hypothesis conform a network of damaging elements, and that all ingredients cause and/or enhances each other. The triggering factor is obviously the interaction between parasite and host's immune system. Cell parasitism, the inflammatory process and consequent necrosis and fibrosis cause damage to contracting myocardium, autonomic system, conduction system and microcirculation. Autonomic damage causes impaired regulation of microvasculature and further alterations in blood flow. Ischemia causes more myocardial damage. Necrosis exposes intracellular epitopes and causes autoantibodies production with more necrosis, fibrosis and so on. It seems that, if adequate down modulator immune mechanisms work properly, this vicious circle stops and patients do not develop cardiomyopathy, rather they

Abel L. C., Rizzo L. V., Ianni B., Albuquerque F., Bacal F., Carrara D., Bocchi E. A., Teixeira

Altschuller M. B., Pedrosa R. C., Pereira Bde B., Correa Filho W. B., Medeiros A. S., Costa P.

Alves M. J. M. & Colli W. (2007). Trypanosoma cruzi: Adhesion to the Host Cell and Intracellular Survival. *IUBMB Life.* Vol. 59, No. 4 - 5, pp. 274 - 279, ISSN 1521-6551 Amorim D. S., Godoy R. A., Manco J. C., Tanaka A. & Gallo L., Jr. (1968). Effects of acute

preliminary report. *Circulation.* Vol. 38, No. 2, pp. 289-294, ISSN 0009-7322 Amorim D. S., Mello de Oliveira J. A., Manco J. C., Gallo L., Jr. & Meira de Oliveira J. S.

Andrade Z. A. (1985). A patologia da doenca de Chagas no honen. *Annales de la Societe Belge* 

Andrade Z. A., Cámara E. J. N., Sadigursky M. & Andrade S. G. (1988). Envolvimento do

Arce-Fonseca M., Ballinas-Verdugo M. A., Reyes P. A., Aranda-Fraustro A. & Monteon V.

*Vector Borne and Zoonotic Diseases.* Vol. 5, No. 3, pp. 233-236, ISSN 1530-3667 Ashton A. W., Mukherjee S., Nagajyothi F., Huang H., Braunstein V. L., Desruisseaux M. S.,

*Medicina Tropical.* Vol. 40, No. 6, pp. 665 - 671, ISSN 0037-8682

H. C., Mady C., Kalil J. & Cunha-Neto E. (2001). Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. *Journal of Autoimmunity.* Vol. 17, No. 1, pp. 99-107,

C. & de Carvalho A. C. (2007). Chronic Chagas disease patients with sinus node dysfunction: is the presence of IgG antibodies with muscarinic agonist action independent of left ventricular dysfunction? *Revista da Sociedade Brasileira de* 

elevation in blood pressure and of atropine on heart rate in Chagas' disease. A

(1973). Chagas' heart disease. First demonstrable correlation between neuronal degeneration and autonomic impairment. *Acta Cardiologica.* Vol. 28, No. 4, pp. 431-

nodulo sinusal na doença de Chagas. *Arquivos Brasileiros de Cardiologia.* Vol. 50, No.

M. (2005). Autoantibodies to human heart conduction system in Chagas' disease.

Factor S. M., Lopez L., Berman J. W., Wittner M., Scherer P. E., Capra V., Coffman

**6. Conclusions** 

**7. References** 

remain in the indeterminate form lifelong.

ISSN 0896-8411

440, ISSN 0001-5385

pp. 153

*de Medecine Tropicale.* Vol. 65, No. 1, pp. 15-30

T. M., Serhan C. N., Gotlinger K., Wu K. K., Weiss L. M. & Tanowitz H. B. (2007). Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. *The Journal of Experimental Medicine.* Vol. 204, No. 4, pp. 929-940


Pathogenesis and Pathology of Chagas' Chronic Myocarditis 141

Davila Spinetti D. F., Inglessis G. & Mazzei de Davila C. A. (1999). Chagas cardiomyopathy

Deghaide N. H., Dantas R. O. & Donadi E. A. (1998). HLA class I and II profiles of patients

Diaz L. A., Arteaga L. A., Hilario-Vargas J., Valenzuela J. G., Li N., Warren S., Aoki V.,

Dutra, Colley, Pinto D., Gazzinelli, Brener, Pereira, Coffman, Correa O. & Carvalho P.

Dutra W. O., Martins-Filho O. A., Cancado J. R., Pinto-Dias J. C., Brener Z., Freeman Junior

Factor S. M. & Sonnenblick E. H. (1982). Hypothesis: Is congestive cardiomyopathy caused

*American Journal of Cardiology.* Vol. 50, No. 5, pp. 1149-1152, ISSN 0002-9149 Fedoseyeva E. V., Zhang F., Orr P. L., Levin D., Buncke H. J. & Benichou G. (1999). De Novo

Ferrans V. J., Milei J., Tomita Y. & Storino R. A. (1988). Basement membrane thickening in

Ferreira R. C., Ianni B. M., Abel L. C., Buck P., Mady C., Kalil J. & Cunha-Neto E. (2003).

Gallo L., Jr., Neto J. A., Manco J. C., Rassi A. & Amorim D. S. (1975). Abnormal heart rate

Garcia Borras S., Racca L., Cotorruelo C., Biondi C., Beloscar J. & Racca A. (2009).

*Cardiologia de Mexico.* Vol. 69, No. 1, pp. 35-39, ISSN 0020-3785

*Journal of Immunology.* Vol. 51, No. 1, pp. 91-97, ISSN 1365-3083

*Immunology.* Vol. 6, No. 4, pp. 499-506, ISSN 0953-8178

*immunology.* Vol. 20, No. 4, pp. 197-203, 0141-9838

*Clinical Microbiological Reviews.* Vol. 19, No. 1, pp. 80-94

*Cardiology.* Vol. 61, No. pp. 1137-1140

3, pp. 147-162, ISSN 0008-6312

246-252, ISSN 0163-2116

1051, ISSN 0022-202X

and the autonomic nervous system. Clinical studies. *Archivos del Instituto de* 

presenting with Chagas' disease. *Digestive Diseases and Sciences.* Vol. 43, No. 2, pp.

Hans-Filho G., Eaton D., dos Santos V., Nutman T. B., de Mayolo A. A., Qaqish B. F., Sampaio S. A. & Rivitti E. A. (2004). Anti-desmoglein-1 antibodies in onchocerciasis, leishmaniasis and Chagas disease suggest a possible etiological link to Fogo selvagem. *The Journal of Investigative Dermatology.* Vol. 123, No. 6, pp. 1045-

(2000). Self and Nonself Stimulatory Molecules Induce Preferential Expansion of CD5+ B Cells or Activated T Cells of Chagasic Patients, Respectively. *Scandinavian* 

G. L., Colley D. G., Gazzinelli G. & Parra J. C. (1994). Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. *International* 

by a hyperreactive myocardial microcirculation (Microvascular spasm)? *The* 

Autoimmunity to Cardiac Myosin After Heart Transplantation and Its Contribution to the Rejection Process. *The Journal of Immunology.* Vol. 162, No. 11, pp. 6836-6842 Fernandez-Mestre M. T., Layrisse Z., Montagnani S., Acquatella H., Catalioti F., Matos M.,

Balbas O., Makhatadze N., Dominguez E., Herrera F. & Madrigal A. (1998). Influence of the HLA class II polymorphism in chronic Chagas' disease. *Parasite* 

cardiac myocytes and capillaries in chronic Chagas' Disease. *American Journal of* 

Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients. *Memorias do Instituto Oswaldo Cruz.* Vol. 98, No. 3, pp. 407-411, ISSN 0074-0276 Fujinami R. S., von Herrath M. G., Christen U. & Whitton J. L. (2006). Molecular Mimicry,

Bystander Activation, or Viral Persistence: Infections and Autoimmune Disease.

responses during exercise in patients with Chagas' disease. *Cardiology.* Vol. 60, No.

Distribution of HLA-DRB1 alleles in Argentinean patients with Chagas' disease


Castro C., Prata A. & Macedo V. (2005). The influence of the parasitemia on the evolution of

Castro R., Kuschnir E. & Sgammini H. (1988). Evaluación de la performance cardíaca y

Chagas C. & Vilella E. (1922). Cardiac form of American trypanosomiasis. . *Memorias do* 

Consolim-Colombo F. M., Lopes H. F., Rosetto E. A., Rubira M. C., Barreto-Filho J. A. S.,

Cossio P. M., Diez C., Szarfman A., Kreutzer E., Candiolo B. & Arana R. M. (1974). Chagasic

Cunha-Neto E., Dzau V. J., Allen P. D., Stamatiou D., Benvenutti L., Higuchi M. L., Koyama

Cunha-Neto E. & Kalilf J. (2001). Heart-infiltrating and Peripheral T Cells in the

Cunha-Neto E., Nogueira L. G., Teixeira P. C., Ramasawmy R., Drigo S. A., Goldberg A. C.,

Davila D. F., Donis J. H., Torres A. & Ferrer J. A. (2004). A modified and unifying neurogenic

*International Journal of Cardiology.* Vol. 96, No. 2, pp. 191-195, ISSN 0167-5273 Davila D. F., Donis J. H., Torres A., Gottberg C. F. & Rossell O. (1991). Cardiac

Davila D. F., Inglessis G. & Mazzei de Davila C. A. (1998). Chagas' heart disease and the

*Revista de la Federación Argentina de Cardiología.* Vol. 17, No. pp. 226 - 231 Chagas C. (1909). Nova tripanozomiaze humana. Estudos sobre a morfolojia e o ciclo

38, No. 1, pp. 1-6, ISSN 0037-8682

*Instituto Oswaldo Cruz.* Vol. 14, No. 1, pp. 5 - 61

Failure. *Endothelium.* Vol. 11, No. 5-6, pp. 241-246

*Human Immunology.* Vol. 65, No. 1, pp. 60-65, ISSN 0198-8859

159 - 218

ISSN 0002-9440

No. 3, pp. 187-192

258, ISSN 1678-8060

No. 2, pp. 80-84, ISSN 0306-9877

123-127, ISSN 0167-5273

the chronic Chagas' disease. *Revista da Sociedade Brasileira de Medicina Tropical.* Vol.

perfusión miocárdica con radiotrazadores en la cardiopatía chagásica crónica.

evolutivo do Schizotripannum cruzi n. gen., n. sp., ajente etiolojico de nova entidade mobida do homem. *Memorias do Instituto Oswaldo Cruz.* Vol. 1, No. 2, pp.

Baruzzi A. C. A., Rocha N. N., Mady C., Irigoyen M. C. & Krieger E. M. (2004). Endothelial Function Is Preserved in Chagas' Heart Disease Patients Without Heart

Cardiopathy: Demonstration of a Serum Gamma Globulin Factor Which Reacts with Endocardium and Vascular Structures. *Circulation.* Vol. 49, No. 1, pp. 13-21 Cruz-Robles D., Reyes P. A., Monteon-Padilla V. M., Ortiz-Muniz A. R. & Vargas-Alarcon G.

(2004). MHC class I and class II genes in Mexican patients with Chagas disease.

N. S., Silva J. S., Kalil J. & Liew C. C. (2005). Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. *The American Journal of Pathology.* Vol. 167, No. 2, pp. 305-313,

Pathogenesis of Human Chagas' Disease Cardiomyopathy. *Autoimmunity.* Vol. 34,

Fonseca S. G., Bilate A. M. & Kalil J. (2009). Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. *Memorias do Instituto Oswaldo Cruz.* Vol. 104 Suppl 1, No. pp. 252-

hypothesis can explain the natural history of chronic Chagas heart disease.

parasympathetic innervation in Chagas' heart disease. *Medical Hypotheses.* Vol. 35,

autonomic nervous system. *International Journal of Cardiology.* Vol. 66, No. 2, pp.


Pathogenesis and Pathology of Chagas' Chronic Myocarditis 143

Gorelik G., Genaro A. M., Sterin-Borda L., Gonzalez Cappa S. & Borda E. S. (1990).

Gruber A. & Zingales B. (1993). Trypanosoma cruzi: characterization of two recombinant

Guerri-Guttenberg R. A., Grana D. R., Ambrosio G. & Milei J. (2008). Chagas

Guzzetti S., Iosa D., Pecis M., Bonura L., Prosdocimi M. & Malliani A. (1991). Impaired heart

Hagar J. M. & Rahimtoola S. H. (1991). Chagas' Heart Disease in the United States. *New* 

Hiss F. C., Lascala T. F., Maciel B. C., Marin-Neto J. A. & Simoes M. V. (2009). Changes in

Huang H., Calderon T. M., Berman J. W., Braunstein V. L., Weiss L. M., Wittner M. &

Huang H., Chan J., Wittner M., Jelicks L. A., Morris S. A., Factor S. M., Weiss L. M.,

Jelicks L. A., Chandra M., Shirani J., Shtutin V., Tang B., Christ G. J., Factor S. M., Wittner

Jones E. M., Colley D. G., Tostes S., Reis Lopez E., Vnencak-Jones C. L. & McCurley T. L.

Jorg M. E. (1974). Tripanosomiasis cruzi: anarquía angiotopográfica por descapilarización

Junqueira Junior L. F., Gallo Junior L., Manco J. C., Marin-Neto J. A. & Amorim D. S. (1985).

Vol. 71, No. 3, pp. 1185-1193, ISSN 0019-9567

*Parasitology.* Vol. 76, No. 1, pp. 1-12, ISSN 0014-4894

121, No. 6 Pt 1, pp. 1727-1734, ISSN 0002-8703

No. 2, pp. 164-172, ISSN 1876-7591

1497-1506, ISSN 0020-7519

*and Hygiene.* Vol. 48, pp. 348-357

*Médica Argentina.* Vol. 61, pp. 94.

*England Journal of Medicine.* Vol. 325, No. 11, pp. 763-768

*Infection and Immunity.* Vol. 67, No. 10, pp. 5434-5440

*Cellular Cardiology.* Vol. 31, No. 1, pp. 75-88, ISSN 0022-2828

236, ISSN 0090-1229

2587-2591

Chagas' disease is due to a Th1-specific immune response. *Infection and Immunity.*

Antibodies bind and activate beta adrenergic and cholinergic lymphocyte receptors in Chagas' disease. *Clinical Immunology and Immunopathology.* Vol. 55, No. 2, pp. 221-

antigens with potential application in the diagnosis of Chagas' disease. *Experimental* 

cardiomyopathy: Europe is not spared!†. *European Heart Journal.* Vol. 29, No. 21, pp.

rate variability in patients with chronic Chagas' disease. *American Heart Journal.* Vol.

myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas' cardiomyopathy. *JACC. Cardiovascular Imaging.* Vol. 2,

Tanowitz H. B. (1999a). Infection of Endothelial Cells with Trypanosoma cruzi Activates NF-kappa B and Induces Vascular Adhesion Molecule Expression.

Braunstein V. L., Bacchi C. J., Yarlett N., Chandra M., Shirani J. & Tanowitz H. B. (1999b). Expression of Cardiac Cytokines and Inducible Form of Nitric Oxide Synthase (NOS2) inTrypanosoma cruzi-infected Mice. *Journal of Molecular and* 

M., Huang H., Weiss L. M., Mukherjee S., Bouzahzah B., Petkova S. B., Teixeira M. M., Douglas S. A., Loredo M. L., D'Orleans-Juste P. & Tanowitz H. B. (2002). Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease. *International Journal for Parasitology.* Vol. 32, No. 12, pp.

(1993). Amplification of Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. *American Journal of Tropical Medicine* 

mesenquimorreactiva, cofactor patogénico de la miocardiopatía crónica. *Prensa* 

Subtle cardiac autonomic impairment in Chagas' disease detected by baroreflex

cardiomyopathy. *Immunological Investigations.* Vol. 38, No. 3-4, pp. 268-275, ISSN 1532-4311


Garcia R., Avila J. L., Rojas M., Martinez A., Garcia W. & Bergel P. (1998). Anti-sulfatide

Gazzinelli R. T. (1991). Natural anti-Gal antibodies prevent, rather than cause,

Giordanengo L., Fretes R., Díaz H., Cano R., Bacile A., Vottero-Cima E. & Gea S. (2000a).

*Experimental Immunology.* Vol. 124, No. 2, pp. 266-273, ISSN 0009-9104 Giordanengo L., Maldonado C., Rivarola H. W., Iosa D., Girones N., Fresno M. & Gea S.

Girones N., Cuervo H. & Fresno M. (2005). Trypanosoma cruzi-induced molecular mimicry

Girones N., Rodriguez C. I., Basso B., Bellon J. M., Resino S., Munoz-Fernandez M. A., Gea

Girones N., Rodriguez C. I., Carrasco-Marin E., Hernaez R. F., de Rego J. L. & Fresno M.

Goin J., Leiros C., Borda E. & Sterin-Borda L. (1997). Interaction of human chagasic IgG with

Goin J. C., Borda E., Leiros C. P., Storino R. & Sterin-Borda L. (1994). Identification of

Goin J. C., Sterin-Borda L., Bilder C. R., Varrica L. M., Iantorno G., Ríos M. C. & Borda E.

Gomes J. A., Bahia-Oliveira L. M., Rocha M. O., Martins-Filho O. A., Gazzinelli G. & Correa-

*of Immunology.* Vol. 30, No. 11, pp. 3181-3189, ISSN 1521-4141

*Immunology.* Vol. 8, No. 6, pp. 1039-1043, ISSN 1071-412X

1532-4311

1020-4989

pp. 164-167, ISSN 0923-2494

pp. 89-123, ISSN 0070-217X

pp. 45-52, ISSN 0165-1838

pp. 798-805, ISSN 0016-5085

9738

83

cardiomyopathy. *Immunological Investigations.* Vol. 38, No. 3-4, pp. 268-275, ISSN

antibody titers in patients with chronic Chagas disease and other forms of cardiopathy. *Revista Panamericana de Salud Publica.* Vol. 3, No. 4, pp. 249-256, ISSN

autoimmunity in human Chagas' disease. *Research in Immunology.* Vol. 142, No. 2,

Cruzipain induces autoimmune response against skeletal muscle and tissue damage in mice. *Muscle & Nerve.* Vol. 23, No. 9, pp. 1407-1413, ISSN 1097-4598 Giordanengo L., Gea S., Barbieri G. & Rabinovich G. A. (2001). Anti-galectin-1

autoantibodies in human Trypanosoma cruzi infection: differential expression of this beta-galactoside-binding protein in cardiac Chagas' disease. *Clinical and* 

(2000b). Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring. *European Journal* 

and Chagas' disease. *Current Topics in Microbiology and Immunology.* Vol. 296, No.

S., Moretti E. & Fresno M. (2001a). Antibodies to an epitope from the Cha human autoantigen are markers of Chagas' disease. *Clinical and Diagnostic Laboratory* 

(2001b). Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease. *The Journal of Clinical Investigation.* Vol. 107, No. 8, pp. 985-993, ISSN 0021-

the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications. *The FASEB Journal.* Vol. 11, No. 1, pp. 77-

antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications. *Journal of the Autonomic Nervous System.* Vol. 47, No. 1-2,

(1999). Functional implications of circulating muscarinic cholinergic receptor autoantibodies in chagasic patients with achalasia. *Gastroenterology.* Vol. 117, No. 4,

Oliveira R. (2003). Evidence that development of severe cardiomyopathy in human

Chagas' disease is due to a Th1-specific immune response. *Infection and Immunity.* Vol. 71, No. 3, pp. 1185-1193, ISSN 0019-9567


Pathogenesis and Pathology of Chagas' Chronic Myocarditis 145

Manço J. C., Gallo L., Jr., Godoy R. A., Fernandes R. G. & Amorim D. S. (1969). Degeneration

Marin-Neto J. A., Cunha-Neto E., Maciel B. C. & Simoes M. V. (2007). Pathogenesis of Chronic Chagas Heart Disease. *Circulation.* Vol. 115, No. 9, pp. 1109-1123 Marin-Neto J. A., Gallo L., Jr., Manço J. C., Rassi A. & Amorim D. S. (1975). Postural reflexes

Marin-Neto J. A., Marzullo P., Marcassa C., Gallo Junior L., Maciel B. C., Bellina C. R. &

Menezes C. A. S., Rocha M. O. C., Souza P. E. A., Chaves A. C. L., Gollob K. J. & Dutra W. O.

*Experimental Immunology.* Vol. 137, No. 1, pp. 129-138, ISSN 1365-2249 Milei J., Fernandez Alonso G., Vanzulli S., Storino R. A., Maturri L. & Rossi L. (1996a).

pp. 879-885, ISSN 0009-7322

No. 8, pp. 780-784, ISSN 0002-9149

*Heart Journal.* Vol. 123, No. 6, pp. 1732-1735

29, ISSN 0002-8703

161-170, ISSN 0300-8177

*Cardiologia.* Vol. 36, No. 2, pp. 107-115

5273

424-437

*Cardiology.* Vol. 60, No. 6, pp. 343-357, 0008-6312

of the cardiac nerves in Chagas' disease. Further studies. *Circulation.* Vol. 40, No. 6,

in chronic Chagas's heart disease. Heart rate and arterial pressure responses.

L'Abbate A. (1992). Myocardial perfusion abnormalities in chronic Chagas' disease as detected by thallium-201 scintigraphy. *The American Journal of Cardiology.* Vol. 69,

(2004). Phenotypic and functional characteristics of CD28+ and CD28− cells from chagasic patients: distinct repertoire and cytokine expression. *Clinical &* 

Myocardial Inflammatory infiltrate in human chronic Chagasic cardiomyopathy: Immunohistochemical findings. *Cardiovascular Pathology.* Vol. 5, No. 4, pp. 209-219 Milei J., Storino R.A., Matturri L., Rossi L. (1996b). Studio anatomo-clinico ed epidemiologico della malattia di Chagas. *Pathologica.* Vol. 88, pp. 117, 127 Milei J., Guerri-Guttenberg R. A., Grana D. R. & Storino R. (2009). Prognostic impact of

Chagas disease in the United States. *American Heart Journal.* Vol. 157, No. 1, pp. 22-

exist as an undiagnosd form of cardiomyopathy in the United States? *American* 

Electrophysiologic-structural correlations in chagasic aneurysms causing malignant arrhythmias. *International Journal of Cardiology.* Vol. 32, No. 1, pp. 65-73, ISSN 0167-

laminin and immunohistochemical localization of laminin in chronic chagasic cardiomyopathy: a review. *Molecular and Cellular Biochemistry.* Vol. 129, No. 2, pp.

Histopathology of specialized and ordinary myocardium and nerves in chronic Chagas disease, with a morphometric study of inflammation and fibrosis.

(1992b). Endomyocardial biopsies in chronic chagasic cardiomyopathy. Immunohistochemical and ultrastructural findings. *Cardiology.* Vol. 80, No. 5-6, pp.

Milei J., Mautner B., Storino R. A., Sanchez J. A. & Ferrans V. J. (1992a). Does Chagas' disease

Milei J., Pesce R., Valero E., Muratore C., Beigelman R. & Ferrans V. J. (1991a).

Milei J., Sánchez J., Storino R., Yu Z.-X., Denduchis B. & Ferrans V. J. (1993). Antibodies to

Milei J., Storino R. A., Beigelman R., Fernandez Alonso G., Maturri L. & Rossi L. (1991b).

Milei J., Storino R. A., Fernandez Alonso G., Beigelman R., Vanzulli S. & Ferrans V. J.

Milei J., Guerri-Guttenberg R. A., Azzato F. & Storino R. (2008). Chagasic Cardiomyopathy: New trends for an old burden, Nova Science Publishers, 978-1-60692-193-7

sensitivity testing. *Brazilian Journal of Medical and Biologival Research.* Vol. 18, No. 2, pp. 171-178, ISSN 0100-879X


Kerner N., Liegeard P., Levin M. J. & Hontebeyrie-Joskowicz M. (1991). Trypanosoma cruzi:

Khoury E. L., Diez C., Cossio P. M. & Arana R. M. (1983). Heterophil nature of EVI antibody

Kierszenbaum F. (2003). Views on the autoimmunity hypothesis for Chagas disease

Köberle F. (1956a). Chagas disease: a disease of the peripheral autonomic nervous system.

Köberle F. (1956b). Pathological findings in muscular hollow organs in experimental Chagas

Köberle F. (1959). Cardiopathia parasympathicopriva. *Münch Med Wochenschr.* Vol. 101, No.

Kumar S. & Tarleton R. L. (1998). The relative contribution of antibody production and

Laranja F. S., Dias E., Nobrega G. & Miranda A. (1956). Chagas' Disease: A Clinical, Epidemiologic, and Pathologic Study. *Circulation.* Vol. 14, No. 6, pp. 1035-1060 Layrisse Z., Fernandez M. T., Montagnani S., Matos M., Balbas O., Herrera F., Colorado I. A.,

Libby P., Alroy J. & Pereira M. E. (1986). A neuraminidase from Trypanosoma cruzi removes

*Journal of Clinical Investigation.* Vol. 77, No. 1, pp. 127-135, ISSN 0021-9738 Llop E., Rothhammer F., Acuna M., Apt W. & Arribada A. (1991). HLA antigens in Chagas

Lopes E. R., Chapadeiro E., Andrade Z. A., Almeida Hde O. & Rocha A. (1981). Pathological

Macedo A. M., Machado C. R., Oliveira R. P. & Pena S. D. J. (2004). Trypanosoma cruzi:

manner. *Memorias do Instituto Oswaldo Cruz.* Vol. 75, No. 2, pp. 189 - 197 Lu B., Luquetti A. O., Rassi A. & PereiraPerrin M. (2010). Autoantibodies to neurotrophic

*Journal of Immunology.* Vol. 71, No. 3, pp. 220-225, ISSN 1365-3083

CD8+ T cell function to immune control of Trypanosoma cruzi. *Parasite* 

Catalioti F. & Acquatella H. (2000). HLA-C(\*)03 is a risk factor for cardiomyopathy in Chagas disease. *Human Immunology.* Vol. 61, No. 9, pp. 925-929, ISSN 0198-8859 Levitus G., Hontebeyrie-Joskowicz M., Van Regenmortel M. H. & Levin M. J. (1991).

Humoral autoimmune response to ribosomal P proteins in chronic Chagas heart disease. *Clinical and Experimental Immunology.* Vol. 85, No. 3, pp. 413-417, ISSN 0009-

sialic acid from the surface of mammalian myocardial and endothelial cells. *The* 

cardiomyopathy: new evidence based on a case-control study. *Revista Médica de* 

anatomy of hearts from asymptomatic Chagas disease patients dying in a violent

receptors TrkA, TrkB and TrkC in patients with acute Chagas' disease. *Scandinavian* 

Genetic Structure of Populations and Relevance of Genetic Variability to the Pathogenesis of Chagas Disease. *Memorias do Instituto Oswaldo Cruz.* Vol. 99, No. 1,

pp. 171-178, ISSN 0100-879X

No. 2, pp. 283-288, ISSN 0090-1229

pp. 1308-1310, ISSN 0027-2973

*Wien Klin Woschenschr.* Vol. 68, No. 17, pp. 333 - 339,

disease. *Zentralbl Allg Pathol.* Vol. 95, No. 7 - 8, pp. 321 - 329,

*Immunology.* Vol. 20, No. 5, pp. 207-216, ISSN 1365-3024

*Chile.* Vol. 119, No. 6, pp. 633-636, ISSN 0034-9887

ISSN 0014-4894

ISSN 0928-8244

9104

pp. 1 - 12

sensitivity testing. *Brazilian Journal of Medical and Biologival Research.* Vol. 18, No. 2,

antibodies to a MAP-like protein in chronic Chagas' disease cross-react with mammalian cytoskeleton. *Experimental Parasitology.* Vol. 73, No. 4, pp. 451-459,

in Trypanosoma cruzi infection. *Clinical Immunology and Immunopathology.* Vol. 27,

pathogenesis. *FEMS Immunology and Medical Microbiology.* Vol. 37, No. 1, pp. 1-11,


Pathogenesis and Pathology of Chagas' Chronic Myocarditis 147

Rassi A., Jr., Rassi A. & Little W. C. (2000). Chagas' heart disease. *Clinical cardiology.* Vol. 23,

Rassi A., Jr., Rassi A. & Marin-Neto J. A. (2010). Chagas disease. *Lancet.* Vol. 375, No. 9723,

Reddy V. S., Harskamp R. E., van Ginkel M. W., Calhoon J., Baisden C. E., Kim I. S., Valente

Reis M. M., Higuchi Mde L., Benvenuti L. A., Aiello V. D., Gutierrez P. S., Bellotti G. &

Ribeiro-Dos-Santos R., Mengel J. O., Postol E., Soares R. A. O., Ferreira-Fernandez E., Soares

Riol-Blanco L., Sanchez-Sanchez N., Torres A., Tejedor A., Narumiya S., Corbi A. L.,

Rossi L. (1988). Neuroanatomopathology of the cardiovascular system., In: *Neurocardiology.*, Kulbertus, H. E. and Franck, G., pp. Futura Publishing Co. Inc., Mount Kisco, N.Y. Rossi L., Storino R., Milei J. & Matturri L. (1994). Depleción neuronal en la enfermedad de

Rossi M. A. & Carobrez S. G. (1985). Experimental Trypanosoma cruzi cardiomyopathy in

Rossi M. A., Gonçalves S. & Ribeiro-dos-Santos R. (1984). Experimental Trypanosoma cruzi

Rossi M. A., Tanowitz H., Malvestio L. M., Celes M. R., Campos E. C., Blefari V. & Prado C.

*British Journal of Experimental Pathology.* Vol. 66, No. 2, pp. 155 - 160

Mechanisms. *PLoS Neglected Tropical Diseases.* Vol. 4, No. 8, pp. e674 Sakai N., Wada T., Yokoyama H., Lipp M., Ueha S., Matsushima K. & Kaneko S. (2006).

*Parasite Immunology.* Vol. 23, No. 2, pp. 93-101, ISSN 1365-3024

*Journal of Cell Physiology.* Vol. 215, No. 3, pp. 697-707, ISSN 1097-4652 Reis D. D., Jones E. M., Tostes S., Jr., Lopes E. R., Gazzinelli G., Colley D. G. & McCurley T.

*Hygiene.* Vol. 48, No. 5, pp. 637-644, ISSN 0002-9637

Vol. 83, No. 2, pp. 165-172, ISSN 0090-1229

pp. 4070-4080, ISSN 0022-1767

239 - 246

216

A. J. & Chandrasekar B. (2008). Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activation.

L. (1993). Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. *The American Journal of Tropical Medicine and* 

Pileggi F. (1997). An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. *Clinical Immunology and Immunopathology.*

M. B. P. & Pontes-De-Carvalho L. C. (2001). A heart-specific CD4+ T-cell line obtained from a chronic chagasic mouse induces carditis in heart-immunized mice and rejection of normal heart transplants in the absence of Trypanosoma cruzi.

Sanchez-Mateos P. & Rodriguez-Fernandez J. L. (2005). The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. *Journal of Immunology.* Vol. 174, No. 7,

Chagas: todo debería revisarse. *Revista Argentina de Cardiología.* Vol. 62, No. 3, pp.

BALB/c mice: histochemical evidence of hypoxic changes in the myocardium.

Cardiomyopathy in BA4LB/c Mice. The Potential Role of Intravascular Platelet Aggregation in its Genesis. *American Journal of Pathology.* Vol. 114, No. 2, pp. 209 -

M. (2010). Coronary Microvascular Disease in Chronic Chagas Cardiomyopathy Including an Overview on History, Pathology, and Other Proposed Pathogenic

Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates

No. 12, pp. 883-889, ISSN 0160-9289

pp. 1388-1402, 1474-547X


Moia B., Rosenbaum M. & Hojman D. (1955). Aneurismas ventriculares en la miocarditis

Molina R. B. G., Matsubara B. B., Hueb J. C., Zanati S. G., Meira D. A., Cassolato J. L., Paiva

Morris S. A., Weiss L. M., Factor S., Bilezikian J. P., Tanowitz H. & Wittner M. (1989).

Mott K. E. & Hagstrom J. W. C. (1965). The Pathologic Lesions of the Cardiac Autonomic

Nachman R. L., Hajjar K. A., Silverstein R. L. & Dinarello C. A. (1986). Interleukin 1 induces

Neu N., Ploier B. & Ofner C. (1990). Cardiac myosin-induced myocarditis. Heart

Oliveira E. C., Fujisawa M. M., Hallal Longo D. E., Farias A. S., Contin Moraes J., Guariento

Oliveira J. S. (1985). A natural human model of intrinsic heart nervous system denervation: Chagas' cardiopathy. *American heart journal.* Vol. 110, No. 5, pp. 1092 - 1098 Palacios-Prü E., Carrasco G. H. A., Scorza C. & Espinosa R. (1982). Ultraestructura

Pereira de Godoy M. R., Cacao J. C., Pereira de Godoy J. M., Brandao A. C. & Silva Rossi

Petkova S. B., Tanowitz H. B., Magazine H. I., Factor S. M., Chan J., Pestell R. G., Bouzahzah

Py M. O., Maciel L., Pedrosa R. C., Nascimento J. H. & Medei E. (2009). The presence of

S. A. R. & Zornoff L. A. M. (2006). Dysautonomia and ventricular dysfunction in the indeterminate form of Chagas disease. *International Journal of Cardiology.* Vol.

Verapamil ameliorates clinical, pathologic and biochemical manifestations of experimental chagasic cardiomyopathy in mice. *Journal of the American College of* 

Nervous System in Chronic Chagas' Myocarditis. *Circulation.* Vol. 31, No. 2, pp.

endothelial cell synthesis of plasminogen activator inhibitor. *The Journal of* 

autoantibodies are not involved in the induction of the disease. *The Journal of* 

M. E., de Almeida E. A., Saad M. J., Langone F., Toyama M. H., Andreollo N. A. & Santos L. M. (2009). Neuropathy of gastrointestinal Chagas' disease: immune response to myelin antigens. *Neuroimmunomodulation.* Vol. 16, No. 1, pp. 54-62,

miocárdica en la enfermedad de Chagas. Diagnóstico diferencial con la miocardiopatía dilatada o congestiva y con las miocardiopatías arrítmicas. *Revista* 

Souza D. (2005). Chagas disease and anticardiolipin antibodies in older adults. *Archives of Gerontology and Geriatrics.* Vol. 41, No. 3, pp. 235-238, ISSN 0167-4943 Petkova S. B., Huang H., Factor S. M., Pestell R. G., Bouzahzah B., Jelicks L. A., Weiss L. M.,

Douglas S. A., Wittner M. & Tanowitz H. B. (2001). The role of endothelin in the pathogenesis of Chagas' disease. *International Journal for Parasitology.* Vol. 31, No. 5-

B., Douglas S. A., Shtutin V., Morris S. A., Tsang E., Weiss L. M., Christ G. J., Wittner M. & Huang H. (2000). Myocardial Expression of Endothelin-1 in Murine Trypanosoma cruzi Infection. *Cardiovascular Pathology.* Vol. 9, No. 5, pp. 257-265,

antiautonomic membrane receptor antibodies do not correlate with brain lesions in Chagas' disease. *Arquivos Brasileiros de Cardiologia.* Vol. 67, No. 3A, pp. 633 - 638

crónica chagásica. *Revista Argentina de Cardiología.* Vol. 22, No. pp.

113, No. 2, pp. 188-193, ISSN 0167-5273

273-286

1423-0216

*Cardiology.* Vol. 14, No. 3, pp. 782-789, ISSN 0735-1097

*Experimental Medicine.* Vol. 163, No. 6, pp. 1595-1600

*Immunology.* Vol. 145, No. 12, pp. 4094-4100

*Latinoamericana de Cardiología.* Vol. 3, No. pp. 115

6, pp. 499-511, ISSN 0020-7519

ISSN 1054-8807


Pathogenesis and Pathology of Chagas' Chronic Myocarditis 149

Sterin-Borda L., Gorelik G. & Borda E. S. (1991). Chagasic IgG binding with cardiac

transmembrane signals. *Clin Immnol Immunopathol.* Vol. 61, No. pp. 387-397 Sterin-Borda L., Leiros C. P., Goin J. C., Cremaschi G., Genaro A., Echagüe A. V. & Borda E.

Storino R. A., Barragan H. & Milei J. (1992). Aspectos epidemiologicos de la enfermedad de

Szarfman A., Terranova V. P., Rennard S. I., Foidart J. M., de Fatima Lima M., Scheinman J.

Talvani A., Rocha M. O., Barcelos L. S., Gomes Y. M., Ribeiro A. L. & Teixeira M. M. (2004).

Talvani A., Rocha M. O. C., Ribeiro A. L., Borda E., Sterin-Borda L. & Teixeira M. M. (2006).

Tanowitz H. B., Gumprecht J. P., Spurr D., Calderon T. M., Ventura M. C., Raventos-Suarez

Tanowitz H. B., Kaul D. K., Chen B., Morris S. A., Factor S. M., Weiss L. M. & Wittner M.

Tanowitz H. B., Morris S. A., Factor S. M., Weiss L. M. & Wittner M. (1992b). Parasitic

Tarleton R. & Zhang L. (1999). Chagas Disease Etiology: Autoimmunity or Parasite

Torres C. M. (1960). Miocitólise e fibrose do miocárdio na doença de Chagas. *Memorias do* 

Tyler K. M. & Engman D. M. (2001). The life cycle of Trypanosoma cruzi revisited.

Vago A. R., Andrade L. O., Leite A. A., d'Avila Reis D., Macedo A. M., Adad S. J., Tostes S.,

Vasconcelos D. F. & Junqueira L. F., Jr. (2009). Distinctive impaired cardiac autonomic

Jr., Moreira M. C., Filho G. B. & Pena S. D. (2000). Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. *The American Journal of* 

modulation of heart rate variability in chronic Chagas' indeterminate and heart diseases. *Journal of Electrocardiology.* Vol. 42, No. 3, pp. 281-289, ISSN 1532-8430

Infection. *The Journal of Parasitology.* Vol. 82, No. 1, pp. 124 - 130

Persistence? *Parasitology Today.* Vol. 15, No. 3, pp. 94 - 99

*International Journal for Parasitology.* Vol. 31, No. pp. 472 - 481

*Pathology.* Vol. 156, No. 5, pp. 1805-1809, ISSN 0002-9440

*Instituto Oswaldo Cruz.* Vol. 58, No. 2, pp. 161 - 182

*Cardiology.* Vol. 29, No. 7, pp. 1851-1865, ISSN 0022-2828

*Experimental Medicine.* Vol. 155, No. 4, pp. ISSN 1161-1171

Storino R. A. & Milei J. (1994). *Enfermedad de Chagas*, Mosby-Doyma, Buenos Aires

*Cardiología.* Vol. 21, No. 3, pp. 239-246

10, pp. 2459-2464, 1286-4579

*Infectious Diseases.* Vol. 166, No. 3, pp. 598-603

Vol. 1, No. 1, pp. 7-15, ISSN 1054-8807

6591

muscarinic cholinergic receptors modifies cholinergic-mediated cellular

(1997). Participation of Nitric Oxide Signaling System in the Cardiac Muscarinic Cholinergic Effect of Human Chagasic IgG. *Journal of Molecular and Cellular* 

Chagas en la Argentina y America Latina. *Revista Federación Argentina de* 

I. & Martin G. R. (1982). Antibodies to laminin in Chagas' disease. *The Journal of* 

Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. *Clinical Infectious Disease.* Vol. 38, No. 7, pp. 943-950, ISSN 1537-

Levels of anti-M2 and anti-[beta]1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease. *Microbes and Infection.* Vol. 8, No. 9-

C., Kellie S., Factor S. M., Hatcher V. B., Wittner M. & Berman J. (1992a). Cytokine Gene Expression of Endothelial Cells Infected with Trypanosoma cruzi. *Journal of* 

(1996). Compromised Microcirculation in Acute Murine Trypanosoma cruzi

diseases of the heart I: Acute and chronic Chagas' disease. *Cardiovascular Pathology.*

fibrocytes in renal fibrosis. *Proceedings of the National Academy Science U S A.* Vol. 103, No. 38, pp. 14098-14103, ISSN 0027-8424


Salomone O. A., Caeiro T. F., Madoery R. J., Amuchástegui M., Omelinauk M., Juri D. &

Sanchez J. A., Milei J., Yu Z. X., Storino R., Wenthold R. J. & Ferrans V. J. (1993).

Sathler-Avelar R., Vitelli-Avelar D. M., Teixeira-Carvalho A. & Martins-Filho O. A. (2009).

Savino W., Villa-Verde D. M., Mendes-da-Cruz D. A., Silva-Monteiro E., Perez A. R., Aoki

Schijman A. G., Vigliano C. A., Viotti R. J., Burgos J. M., Brandariz S., Lococo B. E., Leze M.

Skeiky Y. A., Benson D. R., Parsons M., Elkon K. B. & Reed S. G. (1992). Cloning and

Sousa A. C., Marin-Neto J. A., Maciel B. C., Gallo L., Jr. & Amorim D. S. (1987). Cardiac

Souza P. E., Rocha M. O., Rocha-Vieira E., Menezes C. A., Chaves A. C., Gollob K. J. & Dutra

Souza P. E. A., Rocha M. O. C., Menezes C. A. S., Coelho J. S., Chaves A. C. L., Gollob K. J. &

Sterin-Borda L. & Borda E. (2000). Role of Neurotransmitter Autoantibodies in the

*of Sciences.* Vol. 917, No. 1, pp. 273-280, ISSN 1749-6632

103, No. 38, pp. 14098-14103, ISSN 0027-8424

*American Heart Journal.* Vol. 126, No. 6, pp. 1392 - 1401

*Cytokine & Growth Factor Reviews.* Vol. 18, No. pp. 107 - 124

*Cardiovascular Imaging.* Vol. 2, No. 2, pp. 173-175, ISSN 1936-878X

Vol. 176, No. 1, pp. 201-211, ISSN 0022-1007

8539, pp. 985, ISSN 0140-6736

ISSN 0019-9567

No. 4, pp. 1886 - 1894

1217-1220, ISSN 0002-9149

ISSN 1678-8060

fibrocytes in renal fibrosis. *Proceedings of the National Academy Science U S A.* Vol.

Kaski J. C. (2001). High plasma immunoreactive endothelin levels in patients with Chagas' cardiomyopathy. *The American Journal of Cardiology.* Vol. 87, No. 10, pp.

Immunohistochemical localization of laminin in the hearts of patients with chronic chagasic cardiomyopathy: relationship to thickening of basement membranes.

Innate immunity and regulatory T-cells in human Chagas disease: what must be understood? *Memorias do Instituto Oswaldo Cruz.* Vol. 104 Suppl 1, No. pp. 246-251,

M. d. P., Bottasso O., Guiñazú N., Silva-Barbosa S. D. & Gea S. (2007). Cytokines and cell adhesion receptors in the regulation of Immunity to Trypanosoma cruzi.

I., Armenti H. A. & Levin M. J. (2004). Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end-stage chronic chagas heart disease. *The American Journal of Tropical Medicine and Hygiene.* Vol. 70, No. 2, pp. 210-220, ISSN 0002-9637 Schwartz R. G. & Wexler O. (2009). Early Identification and Monitoring Progression of

Chagas' Cardiomyopathy With SPECT Myocardial Perfusion Imaging. *JACC:* 

expression of Trypanosoma cruzi ribosomal protein P0 and epitope analysis of anti-P0 autoantibodies in Chagas' disease patients. *The Journal of Experimental Medicine.*

parasympathetic impairment in gastrointestinal Chagas' disease. *Lancet.* Vol. 1, No.

W. O. (2004). Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. *Infection and immunity.* Vol. 72, No. 9, pp. 5283-5291,

Dutra W. O. (2007). Trypanosoma cruzi Infection Induces Differential Modulation of Costimulatory Molecules and Cytokines by Monocytes and T Cells from Patients with Indeterminate and Cardiac Chagas' Disease. *Infection and. Immunity.* Vol. 75,

Pathogenesis of Chagasic Peripheral Dysautonomia. *Annals of the New York Academy* 


**1. Introduction** 

myocarditis [Subinas et al., 2005].

implications for a wide range of patients [Azis F et al., 2010].

contributed greatly to the diagnosis of myocarditis.

**2. Myocarditis in HIV positive patients** 

**7** 

*Romania* 

Simona Claudia Cambrea

*"Ovidius" University, Faculty of Medicine* 

**Myocarditis in HIV Positive Patients** 

Myocarditis is an acute or chronic inflammatory process that affects the myocardium in response to the action of various infectious, chemical or physical agents. In most patients the disease is self-limiting. The natural course of myocarditis varies greatly, ranging from an asymptomatic state secondary to local inflammation, through development of dilated cardiomyopathy with a variable course, to fatal heart failure due to disseminated

In patients infected with human immunodeficiency virus (HIV) cardiovascular abnormalities are frequent but clinically discrete. Cardiologists and physicians throughout the world are increasingly reporting cardiac muscle disease in association with HIV. With current advances in HIV and acquired immunodeficiency syndrome (AIDS) management and increased survival, cardiac manifestations of HIV disease including HIV related myocardial disease will become more important and will be encountered more frequently. Because cardiac complications in HIV positive patients are often clinically inapparent, periodic screening of these patients is recommended, especially in those with low CD4 counts or receiving treatment with cardiotoxic drugs. The heart may be a marker of the HIV infected patient's overall health, and a decline in cardiac function should trigger more comprehensive evaluation. As the role of infection and inflammation in many other cardiovascular diseases is now recognized, identification of the molecular mechanisms of HIV related myocaditis might have broader

The diagnosis of myocarditis in HIV positive patients during an acute episode may prove difficult, due to the lack of diagnostic techniques with acceptable degrees of specificity and sensitivity. For these patients although endomyocardial biopsy is still considered the diagnostic gold standard, the developments of new imaging techniques, such as cardiac magnetic resonance imaging (CMR), and nuclear imaging by antimyosin scintigraphy have

HIV infection and AIDS have a well-recognized association with myocarditis and dilated cardiomyopathy [Azis F et al., 2010]. This increased predisposition is multifactorial and may include the direct effects of HIV itself, co-infection by opportunistic organisms, toxic effects of commonly used medications or illicit drugs, and nutritional deficiencies [Azis F et al., 2010]. Further, autoimmunity can be an important contributor to the pathogenesis of cardiomyopathy in these patients as many studies demonstrated the presence of cardiac-

